GoodRx Holdings Inc. (NASDAQ:GDRX)’s traded shares stood at 1.99 million during the last session. At the close of trading, the stock’s price was $6.61, to imply an increase of 2.64% or $0.17 in intraday trading. The GDRX share’s 52-week high remains $20.59, putting it -211.5% down since that peak but still an impressive 42.21% since price per share fell to its 52-week low of $3.82. The company has a valuation of $2.50B, with an average of 2.3 million shares in intraday trading volume over the past 10 days and average of 1.76 million shares over the past 3 months.
Analysts have given a consensus recommendation of a Hold for GoodRx Holdings Inc. (GDRX), translating to a mean rating of 2.60. Of 22 analyst(s) looking at the stock, 0 analyst(s) give GDRX a Sell rating. 1 of those analysts rate the stock as Overweight while 17 advise Hold as 4 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at $0.05.
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
Sponsored
GoodRx Holdings Inc. (NASDAQ:GDRX) trade information
After registering a 2.64% upside in the last session, GoodRx Holdings Inc. (GDRX) has traded red over the past five days. The stock hit a weekly high of 6.68 this Thursday, 03/16/23, jumping 2.64% in its intraday price action. The 5-day price performance for the stock is 20.40%, and 25.90% over 30 days. With these gigs, the year-to-date price performance is 41.85%. Short interest in GoodRx Holdings Inc. (NASDAQ:GDRX) saw shorts transact 11.99 million shares and set a 8.46 days time to cover.
Analysts on Wall Street suggest a consensus price target of $6.95, implying an increase of 4.89% to the stock’s current value. The extremes give us $6.00 and $9.00 for target low and target high price respectively. As such, GDRX has been trading -36.16% off suggested target high and 9.23% from its likely low.
GoodRx Holdings Inc. (GDRX) estimates and forecasts
Looking at statistics comparing GoodRx Holdings Inc. share performance against respective industry, we note that the company has underperformed competitors. GoodRx Holdings Inc. (GDRX) shares are 2.96% up over the last 6 months, with its year-to-date growth rate lower than industry average at -13.33% against -0.90%. Revenue is forecast to shrink -44.40% this quarter before falling -50.00% for the next one. The rating firms project that company’s revenue will grow 2.10% compared to the previous financial year.
Revenue forecast for the current quarter as set by 18 analysts is $178.6 million. Meanwhile, for the quarter ending Mar 2023, a total of 15 analyst(s) estimate revenue growth to $181.77 million.Earnings reports from the last fiscal year show that sales brought in $213.26 million and $203.33 million respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to fall -16.30% before dropping -10.60% in the following quarter.
An assessment of the company’s 5-year growth patterns shows that annual earnings shrunk an estimated -25.10% for the past 5-year period. While 2023 is set for a -29.10% return in earnings, projections for the next 5 years are at 2.14% annually.
GDRX Dividends
GoodRx Holdings Inc. has its next earnings report out between May 08 and May 12. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. GoodRx Holdings Inc. has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.
GoodRx Holdings Inc. (NASDAQ:GDRX)’s Major holders
GoodRx Holdings Inc. insiders hold 5.70% of total outstanding shares, with institutional holders owning 72.00% of the shares at 76.35% float percentage. In total, 72.00% institutions holds shares in the company, led by Vanguard Group, Inc. (The). As of Sep 29, 2022, the company held over 7.83 million shares (or 9.50% of shares), all amounting to roughly $36.57 million.
The next major institution holding the largest number of shares is Light Street Capital Management, Llc with 4.19 million shares, or about 5.08% of shares outstanding. As of the market price on Sep 29, 2022, these shares were worth $19.58 million.
We also have Vanguard Total Stock Market Index Fund and Vanguard Small-Cap Index Fund as the top two Mutual Funds with the largest holdings of the GoodRx Holdings Inc. (GDRX) shares. Going by data provided on Sep 29, 2022, Vanguard Total Stock Market Index Fund holds roughly 2.33 million shares. This is just over 2.83% of the total shares, with a market valuation of $10.9 million. Data from the same date shows that the other fund manager holds a little less at 1.93 million, or 2.34% of the shares, all valued at about 9.01 million.
